Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

0.590

-0.000 (-0.02%)

At close: Mar 9, 2026, 4:00 PM EDT

0.590

0.00 (0.00%)

After-hours: Mar 9, 2026, 5:26 PM EDT

Basel Medical Group Cash Flow Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Net Income	-12.09	2.07	1.78	1.98
Depreciation & Amortization	1.18	0.53	0.56	0.58
Asset Writedown & Restructuring Costs	11.15	-	0.05	-
Provision & Write-off of Bad Debts	-0.44	-0.01	0.16	0.03
Other Operating Activities	-1.07	-0.08	-0.23	0.13
Change in Accounts Receivable	-7.28	-0.42	0.54	0.01
Change in Inventory	-0.3	0.02	-0.02	0
Change in Accounts Payable	4.34	0.39	-0.22	0.06
Change in Other Net Operating Assets	0.18	-	-	-
Operating Cash Flow	-4.34	2.51	2.6	2.79
Operating Cash Flow Growth	-	-3.49%	-6.89%	-
Capital Expenditures	-11.04	-0.01	-0.01	-0.09
Investment in Securities	-0	-	-	-
Investing Cash Flow	-11.04	-0.01	-0.01	-0.09
Short-Term Debt Issued	10.95	1.42	-	-
Long-Term Debt Issued	4	-	-	1.03
Total Debt Issued	14.95	1.42	-	1.03
Short-Term Debt Repaid	-0.11	-0	-	-10.86
Long-Term Debt Repaid	-9.24	-2.92	-2.94	-3.09
Total Debt Repaid	-9.35	-2.92	-2.94	-13.95
Net Debt Issued (Repaid)	5.6	-1.5	-2.94	-12.92
Issuance of Common Stock	9.75	-	-	-
Other Financing Activities	1.56	-0.27	0	-
Financing Cash Flow	16.91	-1.77	-2.94	-12.92
Foreign Exchange Rate Adjustments	-0.5	-	-	-
Net Cash Flow	1.03	0.73	-0.35	-10.22
Free Cash Flow	-15.39	2.5	2.59	2.7
Free Cash Flow Growth	-	-3.56%	-4.07%	-
Free Cash Flow Margin	-127.08%	23.97%	26.61%	25.37%
Free Cash Flow Per Share	-0.82	0.15	0.16	0.17
Cash Interest Paid	0.2	0.41	0.24	0.32
Cash Income Tax Paid	0.65	0.18	0.29	0.03
Levered Free Cash Flow	3.95	1.71	1.89	-
Unlevered Free Cash Flow	4.07	1.82	2.04	-
Change in Working Capital	-3.08	-0	0.29	0.08

Source: S&P Capital IQ. Standard template. Financial Sources.